講演・口頭発表等 - 稲澤　譲治

21. 内藤 諒, 村松 智輝, 谷本 幸介, 稲澤 譲治. 統合的mRNA, miRNA発現情報を基盤とした独自のマイクロRNA標的遺伝子予測データベースの構築(Construction of an in-house microRNA-target prediction database based on an integrative mRNA-microRNA expression data). 日本癌学会総会記事 2019.09.01

22. 井上 純, 岸川 正大, 濱本 英利, 小林 勝則, 藤原 恭子, 稲澤 譲治. 皮膚扁平上皮癌におけるmiR-634軟膏による抗腫瘍効果(Therapeutic potential of the topical treatment of miR-634 ointment for cutaneous squamous cell carcinoma). 日本癌学会総会記事 2019.09.01

23. 岸川 正大, 井上 純, 濱本 英利, 小林 勝則, 朝蔭 孝宏, 稲澤 譲治. 甲状腺未分化癌に対するmiR-634を用いた核酸抗癌剤の開発(Development of miRNA-formulation using miR-634 for anaplastic thyroid cancer therapy). 日本癌学会総会記事 2019.09.01

24. 高川 祐希, 玄 泰行, 村松 智輝, 原田 浩之, 稲澤 譲治. 機能的miRNAライブラリースクリーニングによる、BRD4を標的とする新規癌抑制型miRNAの同定(Function-based microRNA library screening identified novel tumor suppressive microRNAs targeting BRD4). 日本癌学会総会記事 2019.09.01

25. 玄 泰行, 村松 智輝, 井上 純, 稲澤 譲治. 新規癌抑制型miRNAによるMYC標的核酸抗癌治療の可能性(Oligonucleotide therapeutics using a novel tumor-suppressive microRNA targeting MYC pathway). 日本癌学会総会記事 2019.09.01

26. 徐 博, 村松 智輝, 稲澤 譲治. 扁平上皮がん細胞においてピタバスタチンはAKT、ERKの抑制を介して細胞増殖を阻害する(Pitavastatin inhibits the cell growth through the downregulation of AKT and ERK in squamous cell carcinoma). 日本癌学会総会記事 2019.09.01

27. 村松 智輝, 佐藤 拓, 田邉 稔, 稲澤 譲治. 循環腫瘍細胞亜株(Panc-1-CTC)の発現解析から見出したTGFBIの機能解析(Identification and characterization of TGFBI in circulating tumor cell subline from pancreatic cancer cell line). 日本癌学会総会記事 2019.09.01

28. Inazawa J. Exploring novel cancer-related microRNAs and their diagnostic and therapeutic potentials in Personalized Cancer Medicine (PCM). The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.13 Seoul, Korea

29. Furusawa A, Inoue J, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J. Ovarian cancer therapeutic potential of glutamine depletion based on GS expression. . The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.12 Seoul, Korea

30. 1. Takagawa Y, Gen Y, Muramatsu T, Harada H, Inazawa J. xploring novel tumor suppressive microRNAs in OSCC. The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.12 Seoul, Korea

31. Gen Y, Inoue J, Inazawa J. The exploration of novel tumor suppressive miRNAs using function-based miRNA screening. The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.12 Seoul, Korea

32. Kishikawa M, Inoue J, Asakage T, Inazawa J. Therapeutic potential of the topical treatment of miR-634 ointment for skin cancer. The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.12 Seoul, Korea

33. Inoue J, Gokita K, Kojima K, Inazawa J. Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy. The 3rd International Symposium of International Society of Precision Cancer Medicine 2019. 2019.03.12 Seoul, Korea

34. Tanikawa Chizu, Kamatani Yoichiro, Toyoshima Osamu, Sakamoto Hiromi, Ito Hidemi, Takahashi Atsushi, Momozawa Yukihide, Hirata Makoto, Fuse Nobuo, Takai-Igarashi Takako, Shimizu Atsushi, Sasaki Makoto, Yamaji Taiki, Sawada Norie, Iwasaki Motoki, Tsugane Shoichiro, Naito Mariko, Hishida Asahi, Wakai Kenji, Furusyo Norihiro, Murakami Yoshinori, Nakamura Yusuke, Imoto Issei, Inazawa Johji, Oze Isao, Sato Naomi, Tanioka Fumihiko, Sugimura Haruhiko, Hirose Hiroshi, Yoshida Teruhiko, Matsuo Keitaro, Kubo Michiaki, Matsuda Koichi. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21(和訳中). Cancer Science 2018.12.01

35. Sato Taku, Muramatsu Tomoki, Tanabe Minoru, Inazawa Johji. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line(和訳中). Cancer Science 2018.11.01

36. Uehara DT, Tanimoto K, Inazawa J. Targeted next-generation resequencing analysis in 105 subjects with undiagnosed intellectual disability and multiple congenital anomalies. The 68th Annual Meeting of The American Society of Human Genetics 2018.10.17 San Diego, USA

37. 五木田 憲太郎, 井上 純, 石原 比呂之, 小嶋 一幸, 稲澤 譲治. LNPを介したmiR-634の送達による抗腫瘍効果(Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy). 日本癌学会総会記事 2018.09.01

38. 岸川 正大, 井上 純, 濱本 英利, 小林 勝則, 藤原 恭子, 朝蔭 孝宏, 稲澤 譲治. 皮膚癌に対するmiR-634軟膏の塗布による抗腫瘍効果(Therapeutic potential of the topical treatment of miR-634 ointment for skin cancer). 日本癌学会総会記事 2018.09.01

39. 玄 泰行, 井上 純, 稲澤 譲治. 機能的miRNAスクリーニングを用いた、p53不活性型癌に細胞死を誘導するmiRNAの探索(The exploration of miRNAs that induce cell death in p53-inactive cancer cells using functional-miRNA screening). 日本癌学会総会記事 2018.09.01

40. 高田 亮, 赤松 秀輔, 中川 英刀, 高橋 篤, 寺田 直樹, 加藤 陽一郎, 兼平 貢, 杉村 淳, 稲澤 譲治, 小川 修, 小原 航. 日本人における前立腺癌の発症に関連する14遺伝子領域の同定(Identification of fourteen new susceptibility loci for prostate cancer in the Japanese population). 日本癌学会総会記事 2018.09.01